AZD0486 Shows Good Efficacy in Relapsed/Refractory Follicular Lymphoma

Published Date: 03 Jan 2025

Novel CD19xCD3 T-cell engager showed high response rate in phase I study

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Two-part prodrug system activates immune attack only in tumor's unique environment

2.

Never in a million years did I think I'd have to limit my chemotherapy.

3.

Dendritic Cell Therapy Offers No Survival Advantage in Pleural Mesothelioma

4.

New drug combination shows particularly good results in patients with HPV-negative head and neck cancer

5.

Un nou sistem de endoscopică imaging are capacitatea de a detecta mai mulți fluorescent tracers.


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot